Gilead Sciences Inc says it is planning to work with international partners to boost production of its experimental coronavirus drug remdesivir. On Friday, the US Food and Drug Administration (FDA) issued emergency use authorization for the medication made by the California-based company. Remdesivir, which was originally developed as an Ebola drug, is given to hospitalized … Read more
Bemcentinib, an experimental Norwegian cancer drug has become the first to be fast-tracked into UK Government-funded coronavirus trials An experimental Norwegian cancer drug has become the first of six promising coronavirus treatments to be fast-tracked into human coronavirus trials in the UK. The medication, called bemcentinib, could be tested on 120 hospitalised COVID-19 sufferers at … Read more
Pharmaceutical giant AstraZeneca strikes deal with Oxford University to mass produce experimental COVID-19 vaccine for no profit – with first results from human trials expected in June The agreement was announced this morning, with the details set to be finalised It will allow for rapid vaccination around the world, if the jab is proven to … Read more
Remdesivir costs about $1 a day to make, and the CEO of the company that developed it, Gilead, said the firm is committed to ensuring ‘access’ to the drug The US Food and Drug Administration has approved the Ebola drug remdesivir for emergency use on hospitalized coronavirus patients. President Donald Trump announced Friday that doctors … Read more
A new vaccine cleared up HPV infections in women who had precancerous lesions on their cervix – preventing it from developing, according to a new study. The shot injects a protein that triggers the immune system to attack precancerous changes in the cervix, specifically lesions known as CIN. About one-third of women who had the most … Read more
A Seattle ER doctor who had been tirelessly treating people dying of coronavirus became a patient of the infection himself. A Phoenix man went having from minor symptoms to relying on life support in a matter of days. Both men were under 60 and had been otherwise healthy before they found themselves life-threateningly ill with … Read more
Prime Minister Boris Johnson is currently in a London intensive care unit fighting the coronavirus, leaving Britons waiting with bated breath for more news. He posted a video about his symptoms on Friday (pictured) Prime Minister Boris Johnson is currently in a London intensive care unit fighting the coronavirus, with Britain waiting for more updates … Read more
Two coronavirus patients in New York City were treated with a new drug ‘fast-tracked’ for HIV and breast cancer – and they went from being on ventilators in the ICU to regular hospital in a matter of days. Based on the results of a small initial trial, biotech firm CytoDyn believes their drug, leronlimab, has … Read more
Britons infected with coronavirus are among thousands of patients taking part in a European coronavirus mega-trial of four experimental therapies. The trial, called Discovery, includes 3,200 patients who have been hospitalised from the killer virus in the UK, Spain, Germany, France, Sweden and Luxembourg. It will test the effectiveness of four treatments, including a course of … Read more
Gilead Sciences Inc said on Sunday it was temporarily putting new emergency access to its experimental coronavirus drug on hold. Remdesivir has been touted by Donald Trump and credited with helping in the recovery of a 79-year-old Italian man who had the disease. But the drugmaker said in a statement there had been an exponential increase … Read more